Allergologia ed Immunologia Clinica, Ospedale Umberto I, Ordine Mauriziano, Turin, Italy.
Rheumatol Int. 2013 Jul;33(7):1889-93. doi: 10.1007/s00296-011-2346-4. Epub 2012 Jan 6.
Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have poor prognosis, and pulmonary endarterectomy (PEA) is considered the treatment of choice for this condition. We report a case and review the literature of successful PEA for CTEPH due to antiphospholipid syndrome associated with systemic lupus erythematosus. The definitive and decisive approach needed to treat this high-risk patient with a history of comorbidity, long-term illness and poor compliance was found with a therapy of PEA.
患有慢性血栓栓塞性肺动脉高压(CTEPH)的患者预后较差,肺动脉内膜切除术(PEA)被认为是该疾病的首选治疗方法。我们报告了一例由于系统性红斑狼疮相关抗磷脂综合征引起的 CTEPH 成功接受 PEA 治疗的病例,并回顾了相关文献。对于这位具有合并症、长期疾病和较差依从性病史的高危患者,我们发现 PEA 治疗是一种明确且果断的治疗方法。